Refine by
Pharmaceutical Compounding Articles & Analysis
19 news found
Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China โ May 22, 2025โ Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and pharmaceutical developers worldwide. This ...
CD Formulation, a CRO service provider of analysis and testing services, offers a comprehensive range of tests for determining physical parameters in pharmaceutical formulations. These tests play a crucial initial role in ensuring the quality, stability, and efficacy of pharmaceutical products. One of the key tests offered by CD Formulation is the relative density test. This test determines the ...
Famed as a leading provider of chemicals, analytical services, and engineering solutions, Alfa Chemistry recently expressed gratitude to everyone who visited its booth at the ACS Spring 2023 conference in San Diego, California in the past month. The conference, which is one of the largest gatherings of chemists and scientific researchers in the world, provided Alfa Chemistry with an opportunity ...
Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the small molecule injectable market and enabling home health solutions, today announced the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application No. 17/546,880 filed on December 9, 2021 and titled Complexing Agent Salt Formulations of Pharmaceutical Compounds. Bexson’s ...
Supports ongoing transformation of Bayer’s Pharma business to focus on key areas of future medical innovation Transaction value of up to 500 million Euro Closing expected by end of 2022 Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer’s men’s health product Nebido™ (testosterone undecanoate), for a purchase price ...
ByBayer AG
The BIO International Convention just ended on June 16th at San Diego Convention Center. BOC Sciences exhibited a whole set of preclinical CRO & fermentation CDMO services and attracted many interested visitors stopping by to have an informative in-person meeting. BIO International Convention united over 15,000 researchers and top-tier biotech leaders this year to intensively expand their ...
BOC Sciences has placed great emphasis on microbial fermentation techniques for years. Its comprehensive fermentation CDMO services and small microbial molecules have delivered tremendous value to the pharmaceutical industry. And the future looks even better. Pharmaceutical enterprises have been confronted with numerous challenges, such as rising cost pressures and uncertainty in the upstream ...
In a recent statement, the York-based CRO company CD Formulation announces the launch of tailored solutions for increased bioavailability excipients, which aims to tackle the issue of poor bioavailability, a long-lasting challenge in drug development. Many drug candidates unfortunately stopped their way ahead from the discovery pipeline just simply because they are poorly water-soluble, which ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has enrolled the first patient into a Phase 2 clinical trial of GLK-301 for the treatment of signs and symptoms of Dry Eye Disease (DED). ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has enrolled the first patient into a Phase 2 clinical trial of GLK-302 for the treatment of presbyopia. GLK-302 is the second investigational ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine, which has demonstrated at least 10-times (10X) the efficacy compared ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing ...
CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced it has been awarded the International CBD Life Science R & D Excellence Award 2020 by Global Health & Pharma, United Kingdom, a ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced that Fundamental Research Corp (“FRC”), one of the world’s largest independent research houses, has launched coverage ...
Canaquest Medical Corp (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to announce its new partnership with the Canadian Cannabis Dispute Resolution Centre (“CCDRC”), a national ...
Hanover, Germany, October 22, 2020 - Cardior Pharmaceuticals GmbH, a clinical-stage biotech company, focused on the development of noncoding RNA (ncRNA) therapeutics for patients with cardiovascular diseases, today announced a publication in the European Heart Journal (doi:10.1093/eurheartj/ehaa791) demonstrating that repeated treatment with its lead compound CDR132L is safe, improves cardiac ...
Allovate, LLC, a specialty biopharmaceutical company, today announced that the company has signed an exclusive provider agreement with Restore Health to bring the new Allerdent OMIT System™, a personalized toothpaste system for the delivery of allergy immunotherapy, to patients nationwide. Allerdent™ is the first oral mucosal immunotherapy (OMIT) toothpaste system designed to help ...
Allovate, LLC, has signed an agreement with Restore Health, a company specializing in personalized medicine, for the exclusive rights to provide Allerdent™, a new personalized therapeutic toothpaste system for people suffering from allergic rhinitis. Allerdent™ is designed for daily use as part of a normal tooth-brushing regimen and enables allergy sufferers to incorporate ...
EPA Region 7 will begin work next week to remove hazardous chemicals and conduct a radiological assessment of the abandoned and seized Beta Chem Laboratory facility at 14410 West 100th Street, in Lenexa, Kan. Region 7’s On-Scene Coordinators (OSCs) and EPA contractors will begin the removal and assessment work on Monday, May 5. EPA anticipates the work could take about four weeks to ...